Intestinal obstruction associated with cholestyramine therapy.
D002792:Cholestyramine Resin / Q000009:adverse effects* / Q000627:therapeutic use; D005244:Fecal Impaction / Q000139:chemically induced*; D006801:Humans; D007230:Infant, Low Birth Weight; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000139:chemically induced* / Q000188:drug therapy; D007415:Intestinal Obstruction / Q000139:chemically induced*; D007567:Jaundice, Neonatal / Q000188:drug therapy; D008297:Male
D002792:Cholestyramine Resin